Off-label Use of Medicines in COVID-19: A Lesson For Future

AA Hemmati, H Mojiri-Forushani - Coronaviruses, 2024 - ingentaconnect.com
The COVID-19 infection is rapidly spreading worldwide. Treating this new viral infection is a
great challenge worldwide. There is no specific and approved medication for its treatment …

Recent Advances in N-Heterocycles for COVID-19 Treatment-A Mini Review

M Dinodia - Medicinal Chemistry, 2023 - ingentaconnect.com
Severe emergencies occurred across the globe, beginning with the outbreak of SARSCoV in
2002, followed by MERS-CoV in 2012. In December 2019, an acute respiratory syndrome …

[HTML][HTML] Multiorgan failure from excessive polypharmacy self-medication with prescription and non-prescription drugs following SARS-CoV-2 infection: A case report

K Davis, L Ghiggino, N Hasan, E Armstrong… - Clinical Infection in …, 2023 - Elsevier
Background The COVID-19 pandemic has led to unprecedented international collaboration
with rapid vaccine development and rollout. In parallel, the public have been subjected to …

[HTML][HTML] The use of antiviral agents against sars-cov-2: Ineffective or time and age dependent result? a retrospective, observational study among covid-19 older adults

A Desai, G Caltagirone, S Sari, D Pocaterra… - Journal of Clinical …, 2021 - mdpi.com
Background: Our aim was to investigate the impact of therapeutics with antiviral activity
against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on mortality of …

[HTML][HTML] Molecular Docking Studies of Curcumin Analogues against SARS-CoV-2 Spike Protein

JR Nogueira, FA Verza, F Nishimura, U Das… - Journal of the Brazilian …, 2021 - SciELO Brasil
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the etiologic agent of the
current pandemic of coronavirus disease 2019 (COVID-19) that has inflicted the loss of …

A review on the toxic effects of medicines used in corona virus disease 2019 (Covid-19) treatment

A Özlü, G Taner, N Koca - DAHUDER Medical Journal, 2022 - dergipark.org.tr
The novel coronavirus disease 2019 pandemic is affecting all around the world, particularly
healthcare systems. The most critical problem for the COVID-19 infection as an emerging …

[PDF][PDF] Virtual Screening Reveals Potential Anti-Parasitic Drugs Inhibiting the Receptor Binding Domain of SARS-CoV-2 Spike Protein

S Muthusamy, H Gopal, T Manivarma… - J. Virol. Antivir …, 2021 - researchgate.net
Abstract The 2019's COVID-19 outbreak which spread to over 200 countries across the
globe had its origin from the 2002's SARS-CoV-1 epidemic. The corona viruses are single …

Searching for COVID-19 treatments: First, do no harm

R Guharoy, E Krenzelok - American Journal of Health-System …, 2020 - academic.oup.com
Primum non nocere, a Latin phrase that means “first, do no harm,” is attributed to the ancient
Greek physician Hippocrates. It reminds healthcare professionals to consider possible harm …

[PDF][PDF] Harnessing the Potential of Biomaterials for COVID-19 Therapeutic Strategies

T Colombani, ZJ Rogers, L Eggermont… - Emergent …, 2021 - par.nsf.gov
With the emergence of the coronavirus disease 2019 (COVID-19), the world is experiencing
a profound human health crisis. The number of infections and deaths due to the severe …

[PDF][PDF] A Respiratory review on Covid-19: Pathophysiology, diagnosis, treatment, and prevention

S Thapa, SL Nargund, M SureshaBiradar, S Yadav… - Cough, 2022 - academia.edu
Coronavirus Disease-2019 (Covid-19), a global threat, is a viral-born disease affecting the
respiratory tract and causing breathing problems. Due to its high spread nature, it spread …